chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Light flashes; Eye floaters; This is a spontaneous report from a contactable reporter (consumer or non-HCP). The reporter is the patient.  A 71-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 16Sep2021 at 11:45 (Lot number: FE3593) at the age of 71 years as dose 2, single for COVID-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication included: ASPIRIN. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; Lot number: FC3181; Anatomical site: Left arm; Administration time: 10:30), administration date: 26Aug2021, when the patient was 71 years old, for COVID-19 immunisation.  The following information was reported: PHOTOPSIA (non-serious) with onset 20Sep2021 at 08:00, outcome "recovering", described as "Light flashes"; VITREOUS FLOATERS (non-serious) with onset 20Sep2021 at 08:00, outcome "not recovered", described as "Eye floaters". The events "Light flashes" and "Eye floaters" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of photopsia and vitreous floaters.  Additional Information: Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Four days after second shot, the patient got eye floaters, and light flashes. Saw optometrist, eyes checked ok. Flashes had subsided, but had 3 floaters in each eye. He never had floaters before in 71 years. Since the vaccination, the patient had not been tested for COVID-19.
trouble sleeping for the past few weeks due to soreness; soreness in left arm around injection site; This case was reported by a consumer via call center representative and described the occurrence of difficulty sleeping in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included artificial cardiac pacemaker user (pacemaker placed on 21st February 2020 ). Previously administered products included Shingrix (received 1st dose in January 2020 or February 2020 in left arm, see case US2020AMR165198).   In June 2020, the patient received the 2nd dose of Shingrix (intramuscular). On an unknown date, less than 2 months after receiving Shingrix, the patient experienced difficulty sleeping and injection site pain. On an unknown date, the outcome of the difficulty sleeping and injection site pain were not recovered/not resolved.   It was unknown if the reporter considered the difficulty sleeping and injection site pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received second dose about 2 months ago.  The patient reported both doses of Shingrix were given in the left arm. The patient reported soreness in left arm around injection site that started a few weeks ago and was still ongoing. The patient reported trouble sleeping for the past few weeks due to soreness in the left arm and this was still ongoing at the time of reporting. The patient did not have lot or expiration date information for either dose of Shingrix. The reporter did not consent to follow-up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR165198:1st dose
This spontaneous report was received from a nurse refers to a patient of unknown age and gender. Medical history was not reported. The nurse informed that on 18-JUN-2014 the patient was vaccinated with M-M-R II (strength, dosage and route were not reported) lot number: J008720, expiration date: 26-JUL-2015. That may had been improperly stored since February 2014. The thermometer battery ran out in February 2014, so the refrigerator temperature was not able to be confirmed to be within recommended storage temperature since then. The highest temperature the M-M-R II could had been exposed was 70F. Also stated that was no way to determine what the exact temperature was at any given time after 01-FEB-2014 since the battery in the thermometer stopped working. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a health professional via a company representative refers to a patient of unknown age. No medical history or concurrent conditions were reported. On an unknown date in May of 2015, the reporter discussed in an unknown article that she is now pressing "red alert button on the devastating consequences and irrelevancy of the vaccine". The reporter stated in the article that the HPV vaccine is "more dangerous that the HPV Virus". The reporter also stated "there were many unknown severe adverse events that occurred and multiple unknown deaths as there are cervical cancer cases developing each year after vaccination with HPV vaccine". The HPV vaccine discussed in the article could not be verified as GARDASIL, GARDASIL 9 or product from another company. The outcome of cervix carcinoma and death was reported as fatal. The outcome of adverse event was unknown. The reporter considered the events to be related to the suspect therapies. Upon internal review, the events of cervix carcinoma and death were considered to be medically significant. Additional information has been requested.
Symptoms: rapid, pounding heartbeat when lying down; occasional cough at night; shortness of breath when trying to sleep.
Chills, fever, sweating, fatigue and insomnia started within a few hours of vaccine and resolved within roughly 24 hours. Tinnitus started within a few hours of vaccine and is unresolved one week later.
Fever, Diarrhea, FEVER, Chills, swelling injection site Narrative:
hot; itchy; quarter size rash; red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot), PRURITUS (itchy), RASH (quarter size rash) and ERYTHEMA (red) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (hot), PRURITUS (itchy), RASH (quarter size rash) and ERYTHEMA (red). At the time of the report, VACCINATION SITE WARMTH (hot), PRURITUS (itchy), RASH (quarter size rash) and ERYTHEMA (red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Narrative: COVID infection following COVID vaccine series 01/29, Moderna , dose #1 02/26, Moderna , dose #2 09/24 pt cc: chills, cough, fatigue, exposure; daughter 10/01 COVID swab, result: detected 10/01 SARS-COV-2 Variant Sequencing result: pending
This spontaneous report was received from healthcare worker regarding an 8 year old female patient. No historical or concurrent conditions were reported. On 29-OCT-2015, before her ninth birthday, the patient was vaccinated with her first dose of GARDASIL lot # K010215 (expiry date: May 2017). The patient did not experience any adverse effects. No Product Quality Complaint (PQC) was reported. Additional information has been requested.
Rash 1 hours after vaccine, took benadryl, rash resolved the next day
Systemic: Confusion-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Weakness-Mild, Additional Details: Patient received her 1st Moderna booster on 11/19. 1 min after the shot, she fainted and lost her consciousness. RPh ran to get Epipen and instructed the tech to call 911. She regained her consciousness after 10-15 sec of fainting and was laid on the floor to monitor breathing. Mom said patient has history of faiting/passing out after getting shot but had not informed RPh when being asked/before administration. EMS came to take her vitals then sent pt home with her mom
5/17 - diarrhea /headache - 7:00 am - 12:00 pm  also get woozy and off all day and tired 5/18 - severe arthritis attack every joint hands excruciating pain and headache - 6:00 am - 1:00 pm  also tired all day  5/19  stomach cramping diarrhea & headache - noon - still have at 6pm
9-21-09 Mon AM. Daughter called VNA office stating her mother was having reaction @ the site of flu shot given on Fri, Sept 18. Having egg size area of redness and swelling, warm to touch and painful to touch.
I contracted COVID-19 03/13/2021 with symptoms of myalgia for 3 days, fatigue, fever of 101, congestion, dry cough that lasted 1 to 2 weeks. I began recovering from initial symptoms after 3 to 4 days with the cough lingering for 1 to 2 weeks.
This spontaneous report was received from a medical assistant refers to a 4 year old female patient. The patient's concurrent conditions, medical history, drug reactions and allergies were not reported. The patient's concomitant medication included sterile diluent (MRK INJ) (unknown lot and expiration date) used for the reconstitution of M-M-R II. On 08-MAR-2018, the patient was vaccinated with improperly stored M-M-R II (dose, units, frequency and route not reported) (lot# N010495 and expiration date: 31-MAR-2019) at a temperature from 47 Fahrenheit (F) to 77 F for 21 hours 45 minutes. No adverse effects were reported. No previous temperature excursion was occurred to the vaccine GARDASIL 9. Data logger was involved. No product quality complaint was involved. This is one of the 4 reports received from the same reporter. Sender's Comments: US-009507513-1803USA004556: US-009507513-1803USA005945: US-009507513-1803USA005946.
Small flaky patch on my chin. I just put prescription cortisone on it. Estimated due date for pregnancy 06/26/2021. No issues with pregnancy.
Patient mother noted she has history of fainting after vaccinations.  Gave vaccine in left arm with patient seated.  After vaccination she walked to waiting area and sat down.  after approximately 5 minutes, mother noted that she had passed out briefly.  Patient was seated and did not fall out of chair.  Mother had brought with them cold compress and bottle of water.  After approximately 15 minutes, patient was back to normal and walked out of store under own power.
I had a severe headache, sore throat, drainage down my throat. I still have the congestion and drainage and headache. I took an antiviral molnupiravir and still on it. I started this on 12/2.
This spontaneous report as received from a consumer (the patient's wife) via Pfizer (MFR report number: 2014295257) refers to a male patient of unknown age. The patient's concurrent conditions and medical history was not provided. On an unkonwn date, the patient was vaccinated with PNEUMOVAX 23 (dose, route of administration, lot number and expiration date were not reported). Concomitant therapies included influenza virus vaccine (unspecified). The consumer reported that, on an unknown date, after receiving PNEUMOVAX 23, her husband experienced unspecified adverse event. The outcome of adverse event was unkonwn. The relatedness between the event and the vaccination with PNEUMOVAX 23 was not provided. Additional information has been requested.
a little bit but not that aggressive after Dose 1; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (a little bit but not that aggressive after Dose 1) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced VACCINATION COMPLICATION (a little bit but not that aggressive after Dose 1). At the time of the report, VACCINATION COMPLICATION (a little bit but not that aggressive after Dose 1) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No Treatment medications were provided. Patient also states that she has constipation issues, that in October it was very serious and started taking Miralax.   This case was linked to MOD-2021-418185 (Patient Link).
After receiving vaccine, patient became light headed and passed out sitting in chair. diaphoretic and clammy. Heartrate 60, BP 60/29,SPO2 100%. Medical response called, patient taken to ER, accompanied by mother
73-year-old male presenting to the ER with worsening shortness of breath.  COVID-19 test positive.   Will follow COVID-19 protocol with most updated research.  Will treat the patient with azithromycin and Rocephin for antimicrobial coverage.  Will follow patient's laboratory values including lactic acid as necessary, CPK, procalcitonin, LDH, ferritin, interleukin 6, triglycerides.  During any hypoxemic episodes the  patient will be provided Decadron for steroid therapy and will be provided DVT prophylaxis with heparin products.  Will check MRSA and Staph aureus nasal swab.  Will also check coagulation studies with PTT and PT INR.  Patient to receive bronchodilator therapy per COVID-19 protocoPfizer 2/22/21 & 3/16/21 Patient admitted 2/16/22, discharged 2/18/22
runny nose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RHINORRHOEA (runny nose). At the time of the report, RHINORRHOEA (runny nose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information was not provided.  Treatment information was not provided.
Patient became dizzy and nauseated upon standing. Patient sat down, and then lied on back; and became nauseated again. Patient vomited once. Rested for several minutes after, with an ice pack and juice. Left 15 minutes later after reporting no dizziness or further nausea.
Breakthrough case admission after 4 vaccines Pfizer 1/2/21 Lot# EL9261;  Pfizer 2/19/21 Lot# EM9810;  Pfizer 9/27/21 Lot# FF8841;  Pfizer 5/23/22 Lot# FM0173
T103 in ER, 2 seizures @ home about 12hrs p/vax; parent had been giving APAP q 4hrs since vax recvd;
Patient received her 2nd dose on 3/4/21.  Today, she woke up with the right side of her face swollen and patchy.  Her right arm is also red and itchy all the way down to her fingers.  Her daughter called the pharmacy and feared that she might have Bell's Palsy.  She took her mom to a walk-in clinic.  The doctor's office blamed the COVID vaccine for her symptoms and said that she is to never receive another COVID vaccination in the future.  I am unaware of the treatments that the patient received
Vertigo; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo) and DIZZINESS (Dizziness) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LISINOPRIL and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced VERTIGO (Vertigo) and DIZZINESS (Dizziness). At the time of the report, VERTIGO (Vertigo) and DIZZINESS (Dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was administered by patient for events.  No medical history information was provided.
Pt received her 1st PCV vaccine on 9/9/09 and passed on 9/10/09. The circumstances surrounding her demise are unclear at moment. Dx as SID.  12/18/09 Autopsy Received. DOD 9/20/09. Cause of Death: Sudden Explained Infant Death. Additional Information Abstracted: Final Other Significant Conditions - Bed Sharing With Adult.
Passed out and was unconscious for approximately 5 minutes; Nausea; Tightening or squeezing sensation of my chest; Tired; Vasovagal event; A spontaneous report was received from a healthcare professional who is the patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced tightening or squeezing sensation in my chest, passed out, unconscious for approximately 5 minutes, nausea, vasovagal event and tired.   The patient's medical history was not provided. No concomitant product use was reported.  On 28 Jan 2021, the patient received their second of two planned doses of mRNA-1273 (Lot number: not provided) for prophylaxis of COVID-19 infection.   On 29 Jan 2021, at 01:30, the patient reported they started to feel a tightening or squeezing sensation in their chest.   On 29 Jan 2021 at 02:30, the patient's symptoms worsened, they reported increased chest tightening and were nauseated. The patient went into their bathroom and "I passed out and ended up on the floor". The patient reported they were unconscious for approximately 5 minutes. The patient's wife called 911 due to chest pains and to rule out a mild heart attack. The patient stated, "all tests came back negative". The patient stated they had a vasovagal event while in the hospital with a blood pressure reading of 77/40. Patient feeling better now, but still tired".  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not provided.   The outcome of the events, tightening or squeezing sensation in my chest, passed out, unconscious for approximately 5 minutes, nausea, vasovagal event and tired, were considered unknown.; Reporter's Comments: This spontaneous report from a healthcare professional of unknown gender who experienced the serious events of unconscious, passed out and tightening or squeezing sensation in my chest and non-serious events of nausea, vasovagal event and tired. The events occurred 1 day after the administration of mRNA-1273 vaccine (Lot number: unknown, expiration date: unknown). Treatment given was not provided and outcome is resolved. Based on the information provided which shows a temporal association a causal association, between the reported events and the administration of mRNA-1273 vaccine cannot be excluded. The events of nausea and fatigue are consistent with the known safety profile of mRNA -1273 vaccine.
When I received my first Covid vaccine, my elbow hurt almost immediately for a weekend. The second dose, my elbow hurt immediately as well. It has been a week and the pain continues with a burning sensation now. It hurts to move my arm and I have no strength due to the pain in the joint.
Itching rash, pustules, starting at inside of knees, on the back and on inside of upper arms
Patient's arm got swollen when immunization was administered. The patient was given Benadryl by mouth
Pt vaccinated with DTP developed redness around injection site with slight temp (99.9 rectal). child now doing fine.
Small amount of vaccine leakage observed between needle hub and syringe as vaccine was administered.  No AE.
Information has been received from an approximately 60 years old male patient concerning himself. The patient was allergic to penicillin or derivative. The patient had no medical history. On an unknown date (reported as on Tuesday) the patient was vaccinated with a dose of ZOSTAVAX (one shot, lot# and route were not reported) in the right arm. No concomitant medications was reported. On Thursday night his arm started hurting and he had a large know with swelling about the size of a half a dollar show up, he put ice on it and the swelling went down. On 15-MAY-2015 (reported as today) in the morning his left knee hurt but it went away. Now his right knee was hurting and was locking up, the pain from one to ten was a 9.75. He sought medical attention via calling his doctor but had not gotten a call back. No treatment was given for these events. No lab diagnostics studies were performed. The outcome of left knee hurt was recovered on 15-MAY-2015, the outcome of right knee hurt was not recovered, the outcome of swelling was recovering, the outcome of other events was unknown. The relationship between these events and ZOSTAVAX was not reported. Additional information has been requested.
Had reaction left arm from PNEUMOVAX last eve. Noted 4x6 swelling and redness below injection site. Difficulty raising arm. Swelling less this arm and about 2 area below inj. site with redenned area. Has taken TYLENOL, ALLEGRA and drinking lots of water.
This is a spontaneous report from a contactable consumer or other non hcp. An 83-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1ST DOSE, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient conveys she had an earache that started five hours ago on an unknown date and wanted to know whether she could take Tylenol. The outcome of the event was unknown.  Information on the Lot/Batch number has been requested. Follow-up attempts are completed. No further information is expected.
Reporter indicated that over the past year there was a 50% rate of non-response in a group of 40-50 pt who were givan a series of 3 Engerix-B vax;7 out of 26 did not seroconvert following vax;
Neurological: tingling in arms, legs, face, tongue. Effects still persist and have not subsided (12 days later so far) General: Low grade fever 100.1 within 24 hours lasting no more than 4 hours, mild joint pain
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. In approximately August 2015 (reported as since 06-AUG-2015), the patients had been administered doses of improperly stored oral, ROTATEQ lot # K010222, expiration date reported as 12-MAY-2016 (dose, route and site of administration were not reported). No adverse effects were reported. This is one of several reports from the same reporter. Additional information has been requested.
child developed 102 F fever, fatigue, sore throat and cough at 02:00 on 11Jan2020 treatment with motrin and tylenol as of 15Jan2020 child is still recovering
Started having blank stares after 24 hours it became increasingly concerning so we went to ER they ran tests and showed she had constant seizure activity. Put on a pharmaceutical with no help. Continues to have constant seizures.
The patient had flu-like symptoms on 03/25/2021 with 103 degrees Fahrenheit; The patient had flu-like symptoms on 03/25/2021 with 103 degrees Fahrenheit; This is a spontaneous report from a contactable consumer (patient) from Pfizer sponsored program. A 58-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, on 24Mar2021 (at the age of 58-years-old) as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 24Mar2021, patient wife experienced migraine the whole day while patient had flu-like symptoms on 25Mar2021 with 103 degrees Fahrenheit.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
low grade temperature 100.0 F, limp listless, EKA CT scan lab normal
Bells Palsy occurred 1 days after receiving flu vax and hep B vax
p/receiving vax feverish & very pale-took pt for blood work 4 days prior to death-due to paleish face;went into a sx disorder & went into cardiac arrest was pronounced dead on arrival;
Soreness in right arm. States had to do some lifting and movements. Hurts to do push ups.
Severe giant hives with severe itching symptoms started 5-7 days after the vaccine in same arm as injection and spreading.